For Q4 FY24, Shilpa Medicare:dna:
reported the following consolidated financial results:
Net profit was 245 million rupees, compared to a loss of 81 million rupees year-over-year (YoY). Revenue increased to 2.92 billion rupees, up from 2.64 billion rupees YoY. EBITDA rose to 699.2 million rupees from 370.2 million rupees YoY, with an EBITDA margin of 23.97% 
, up from 14.05% YoY. The company had an exceptional item of a 61.3 million rupee loss.
Shilpa Medicare has achieved significant financial improvement, transitioning from a net loss to a net profit, with notable increases in revenue and EBITDA.
Seems to be a turnaround candidate getting ready within next 2-4 quarters. Company sitting on a huge operating leverage it can start kicking in numbers after 2-3 quarters anytime. Keep an eye on this. I guess this is the sixth consecutive quarter where the numbers have been improved.
| Subscribe To Our Free Newsletter |
